Time trends of ovarian cancer incidence in China
- PMID: 24528025
- DOI: 10.7314/apjcp.2014.15.1.191
Time trends of ovarian cancer incidence in China
Abstract
The aim of this study was to examine the trend of ovary cancer incidence from 1999 to 2010 in China and predict the burden up to 2020. Crude incidence, age specific incidence and age-adjusted incidence rates were calculated. Joinpoint regression was performed to obtain estimated annual percentages and Bayesian age-period- cohort modeling was used to predict the incidence rate until the year 2020. In China, the crude rate of ovary cancer was 7.91/100,000 and the age-adjusted rate was 5.35/100,000 overall during period 1999-2010. The rates in urban regions were higher than in rural regions. A significant rising trend during 1999-2006 was followed by a drop during 2006-2010 in age-adjusted rates for urban females. In contrast, constant rise was observed in rural women. The decrease in ovary cancer of urban areas tended to be restricted to women aged 50 years and younger. In contrast, increases of ovary cancer in rural areas appeared in virtually all age groups. Although the age-adjusted incidence rate for ovary cancer was predicted to be reduced after year 2011, the crude rate was likely to be relative stable up to 2020. The burden of ovary cancer in China will continue to be relative stable due to the aging population.
Similar articles
-
[Trend analysis and prediction of cancer incidence in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):581-6. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943910 Chinese.
-
[Analysis and prediction of esophageal cancer incidence trend in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):593-7. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943912 Chinese.
-
Long-term trends of liver cancer mortality by gender in urban and rural areas in China: an age-period-cohort analysis.BMJ Open. 2018 Feb 8;8(2):e020490. doi: 10.1136/bmjopen-2017-020490. BMJ Open. 2018. PMID: 29439081 Free PMC article.
-
[Analysis on incidence and mortality of ovarian cancer in Jiangsu province, 2006-2015].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1859-1864. doi: 10.3760/cma.j.cn112338-20200302-00231. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 33297651 Chinese.
-
[Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014].Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jun 6;52(6):579-585. doi: 10.3760/cma.j.issn.0253-9624.2018.06.005. Zhonghua Yu Fang Yi Xue Za Zhi. 2018. PMID: 29886678 Chinese.
Cited by
-
Women's cancers in China: a spatio-temporal epidemiology analysis.BMC Womens Health. 2021 Mar 20;21(1):116. doi: 10.1186/s12905-021-01260-1. BMC Womens Health. 2021. PMID: 33743648 Free PMC article.
-
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.Oncotarget. 2016 May 31;7(22):32433-48. doi: 10.18632/oncotarget.8653. Oncotarget. 2016. PMID: 27074572 Free PMC article.
-
Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway.Braz J Med Biol Res. 2020;53(6):e8885. doi: 10.1590/1414-431x20208885. Epub 2020 May 8. Braz J Med Biol Res. 2020. Retraction in: Braz J Med Biol Res. 2025 Jun 16;58:e8885retraction. doi: 10.1590/1414-431X2025e8885retraction. PMID: 32401925 Free PMC article. Retracted.
-
NF-κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-α and TGF-β.Int J Clin Exp Pathol. 2019 Jan 1;12(1):101-112. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933724 Free PMC article.
-
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts.Front Immunol. 2017 Jun 1;8:607. doi: 10.3389/fimmu.2017.00607. eCollection 2017. Front Immunol. 2017. PMID: 28620375 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical